Ingrid Hoos

Consigliere Generale presso ETON PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Posizioni attive di Ingrid Hoos

Società	Posizione	Inizio	Fine
ETON PHARMACEUTICALS, INC.	Consigliere Generale	-	-

Società	Posizione	Inizio	Fine
Baxter Healthcare, Inc.	Corporate Officer/Principal	-	-
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	Consigliere Generale	-	-

Northeastern Illinois University

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

General Counsel	2
Undergraduate Degree	1
Corporate Officer/Principal	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ETON PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	Health Technology
Baxter Healthcare, Inc.

Aziende private

Health Technology

Baxter Healthcare, Inc.